Mother seeks £3.05m for son’s rare disease treatment

Fayuvi has been approved in the US but remains under review in the UK. The family’s estimated costs and Tate’s eligibility for treatment have yet to be confirmed.

Fayuvi has been approved in the US but remains under review in the UK. The family’s estimated costs and Tate’s eligibility for treatment have yet to be confirmed.
Recent news with a spread of topics.








Palestinian and Sudanese representatives said US visa decisions had prevented their delegates from attending meetings. Washington said it took its responsibilities as UN host seriously.

The Los Angeles Times reports that the federal case follows a search of storage units in California.

Democratic gains have prompted warnings about future defence cooperation and sharpened Israel’s debate over who should lead its next government.

Democrats’ gains have strengthened their position ahead of the next presidential election, but both parties face unanswered questions about their candidates and direction.

Official figures show manufacturing employment rose by 19,000 in October and by 101,000 since December. The White House credits tariffs and tax cuts, but the jobs report does not establish their effect.

US shares linked to artificial intelligence fell sharply after Democrats won control of Congress. But concerns about the cost and returns of AI investment were already weighing on technology stocks.

The Nasdaq rose 1.4% shortly after Friday’s opening, recovering some ground after its steepest daily fall since April last year. The S&P 500 also gained, but the Dow continued lower.

Tesla will wind down Cybertruck production at its Texas factory next year to make room for more Cybercab production, Elon Musk says. It remains unclear whether the truck will be discontinued or built elsewhere.